ARUN LAKHANPAL
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology LAWRENCEVILLE, GA NPI 1356367684
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology GA Lilly USA, LLC All categories
General Payments — all program years on this page
$5,261.78
- Category: General Payments
- Program years: PY2018–2024
- Record count: 210
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,124.35 across 87 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,124.35 | 87 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $230.21 | 9 |
| EMD Serono, Inc. | $216.05 | 5 |
| ARGENX US, INC. | $197.11 | 6 |
| PFIZER INC. | $187.48 | 11 |
| EISAI INC. | $176.25 | 8 |
| UCB, Inc. | $136.27 | 6 |
| Neurelis, Inc. | $110.49 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $96.18 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $85.48 | 4 |
| SK Life Science, Inc. | $83.76 | 3 |
| ABBVIE INC. | $73.75 | 4 |
| Alexion Pharmaceuticals, Inc. | $71.14 | 3 |
| Octapharma USA, Inc. | $64.98 | 3 |
| MDD US Operations, LLC | $54.40 | 2 |
| Lundbeck LLC | $49.86 | 2 |
| ANI Pharmaceuticals, Inc. | $49.13 | 2 |
| JAZZ PHARMACEUTICALS INC. | $46.64 | 2 |
| GE HEALTHCARE | $27.85 | 1 |
| LivaNova USA, Inc. | $24.77 | 1 |
| Otsuka America Pharmaceutical, Inc. | $23.00 | 1 |
| Amneal Pharmaceuticals LLC | $22.16 | 1 |
| Kedrion Biopharma, Inc. | $21.34 | 1 |
| CSL Behring | $20.34 | 1 |
| Amgen Inc. | $18.68 | 1 |
| Alnylam Pharmaceuticals Inc. | $18.59 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $18.44 | 1 |
By program year
Records — PY2024 (87)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.